Tofil-Kaluza A

Compass Pathfinder Ltd (A Subsidiary of Compass Pathways Plc), London, UK.

1 paper

ArticlePsilocybin

Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial.

McGowan NM, Rucker JJ, Yehuda R +6